跳至主要内容
临床试验/NCT05277909
NCT05277909已完成不适用

Effectiveness of an Expert Assessment and Individualised Treatment in Comparison to a Minimal Home-based Exercise Program in Women With Late-term Shoulder Impairments After Primary Breast Cancer Surgery.

Vejle Hospital2 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2022年4月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
31
试验地点
2
主要终点
Change in Shoulder Pain and Disability Index (SPADI) from baseline to 12 weeks after initiating the treatment.

研究概览

简要总结

In breast cancer patients late-term upper limb sequelae, such as shoulder pain and impaired shoulder function remain common after primary breast cancer surgery. The aim of this trial is to evaluate whether an expert assessment of shoulder impairments, followed by an individualised treatment plan, is superior to a minimal physiotherapeutic rehabilitation program in reducing shoulder symptoms, assessed 12 weeks after initiation of treatment, among women with late-term shoulder impairments after primary breast cancer surgery.

详细描述

Worldwide, breast cancer is the second most common cancer. Internationally, an age-standardised incidence rate between 83.1 and 111.9 per 100.000 women is seen, with Denmark taking an unfortunate second place. Standard surgical treatment in Denmark is breast-conserving surgery (BCS) or mastectomy in combination with sentinel lymph node dissection (SLND) or axillary lymph node dissection (ALND). In part due to early diagnosis and optimised treatment methods, 5-year survival has improved to a current 87%. Despite fewer mastectomies and more BCS, less invasive surgical procedures of the axilla (e.g. fewer ALND vs. SLND), and more refined radiotherapy procedures, late-term upper limb impairment still remains common. The most frequent are lymphoedema, sensory disturbances, pain and impaired shoulder function, with up to 70% of patients reporting at least one of these symptoms three years after surgery. These impairments lead to difficulties in activities of daily living, increased risk of depression and anxiety and decreased quality of life (QoL).

Previous research has primarily focused on prevention and treatment of lymphedema, and less on other upper limb impairments. Pre- and early postoperative physiotherapeutic interventions are known to be effective in reducing shoulder pain and improving shoulder function after breast cancer treatment. Nonetheless, late-term upper limb impairments need further focus with prevalence´s of up to 50% is reported for impaired shoulder function and pain up to 6 years after surgery, and a substantial knowledge gap exists as to how to help these women. Currently, no standardised evaluation of their impairments or treatment is offered, and it is therefore up to the individual woman to seek care, resulting in large variations in rehabilitation. Thus a substantial knowledge gap exists in how to meet the rehabilitation needs of these women and evaluation of the actual burden of late-term shoulder impairments after primary treatment for breast cancer and the effect of different treatment strategies is warranted.

The primary aim of this study is to investigate whether the effect of a patient-centred specialised intervention, consisting of an expert assessment followed by an individualised treatment plan (i.e. Intervention group), is superior to a minimal physiotherapeutic rehabilitation program delivered in a pamphlet (i.e. Control comparator group) among women with late-term shoulder impairments 3-7 years after their primary breast cancer surgery. The hypothesis is that women randomised to the Intervention Group will improve significantly more in shoulder function and pain 12 weeks after initiating the treatment than those randomised to the Control comparator group.

This trial is a stratified (by type of surgery and radiotherapy), block randomised (1:1 allocation), controlled, parallel group and assessor blinded superiority trial conducted in Denmark. 130 participants with late-term shoulder impairments 3-7 years after primary surgery for breast cancer will be recruited.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 78 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Breast cancer patients who underwent unilateral BCS or mastectomy on the left or right side, including SLND or +/- ALND within the last 3-7 years (2015-2019)
  • Currently living in the Region of Southern Denmark or Central Denmark Region with a radius of 75 km from Vejle Hospital
  • Between 18 and 71 age on time of surgery for primary breast cancer
  • Indicate pain in chest and/or shoulder area (shoulder impairments) as the biggest problem/late-term effect in everyday life
  • Indicate impaired shoulder function due to pain or due to tightness/tension
  • Indicate shoulder pain at rest, during general activities, during sleep or during flexion, rotation or abduction of the shoulder
  • A score ≥15 on the Disabilities of the Arm, Shoulder and Hand (Quick DASH)
  • Agree to participate in this trial and signs written informed consent

排除标准

  • No previous breast cancer (before 2014)
  • Cancer relapse after the date of index surgery, cancer spread outside of thorax and axilla, tumor fixed to chest wall
  • Primary- or secondary breast reconstruction performed at any time
  • Severe lymphedema (an average score ≥ 70% in the first 7 questionnaires on the LYMPH-ICF-DK
  • Bilateral breast cancer surgery
  • Previous surgery in the affected shoulder (prior to inclusion)
  • Previous shoulder or upper limb fractures (left/right)
  • Currently receiving chemo, immuno- or radiotherapy
  • Co-morbidity expected to influence shoulder function (e.g. rheumatoid arthritis, previous stroke, multiple sclerosis)
  • Other reasons for exclusion (e.g. pregnancy, not legally competent, unable to comprehend the information or unable to consent)

结局指标

主要结局

Change in Shoulder Pain and Disability Index (SPADI) from baseline to 12 weeks after initiating the treatment.

时间窗: 0, 4, 8 and 12 weeks

SPADI is a 13-item patient-reported outcome measure to assess shoulder pain (5 items) and shoulder function (8 items) within the last week. The items are scored on a numeric rating scale that ranges from 0 (no pain/no difficulty) to 10 (worst pain/so difficult that required help). Each domain score is equally weighted and added to a total percentage score that ranges from 0 (best) to 100 (worst). The higher the score, patients reported shoulder impairments. The region specific questionnaire can be used in patients with different or unspecified shoulder diagnoses. SPADI is valid, reliable and responsible measure among patients with shoulder impairments.

次要结局

  • Change in SPADI pain from baseline to 12 weeks after initiating the treatment.(0, 4, 8 and 12 weeks)
  • Change in SPADI function from baseline to 12 weeks after initiating the treatment.(0, 4, 8 and 12 weeks)
  • Global Perceived Effect (GPE) measured at 4, 8 and 12 weeks after initiating the treatment.(4, 8 and 12 weeks)
  • Change in shoulder pain during general activities within the previous 24 hours in the affected shoulder measured by Numeric Rating Scale (NRS) from baseline to 12 weeks after initiating the treatment.(0, 4, 8 and 12 weeks)
  • Change in shoulder pain at rest within the previous 24 hours in the affected shoulder measured by Numeric Rating Scale (NRS) from baseline to 12 weeks after initiating the treatment.(0, 4, 8 and 12 weeks)
  • SPADI clinical response.(12 weeks (follow-up))
  • Change in maximum shoulder pain intensity within the previous 24 hours in the affected shoulder measured by Numeric Rating Scale (NRS) from baseline to 12 weeks after initiating the treatment.(0, 4, 8 and 12 weeks)
  • Change in shoulder pain assessment during flexion/rotation/abduction in the affected shoulder measured by Numeric Rating Scale (NRS) from baseline to 12 weeks after initiating the treatment.(0 and 12 weeks)
  • Change in Active Range Of Motion (A-ROM) in the affected shoulder from baseline to 12 weeks after initiating the treatment.(0 and 12 weeks)
  • Change in Passive Range Of Motion (P-ROM) in the affected shoulder from baseline to 12 weeks after initiating the treatment.(0 and 12 weeks)
  • Number of treatments received due to shoulder symptoms from baseline to 12 weeks after initiating the treatment.(12 weeks (follow up))
  • Change in shoulder pain during sleep within the previous 24 hours in the affected shoulder measured by Numeric Rating Scale (NRS) from baseline to 12 weeks after initiating the treatment.(0, 4, 8 and 12 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

已完成
不适用
Design and Evaluation of the Effects of a Physical Therapy Program With Digital Support in Patients With Breast CancerBreast Cancer
NCT04837248Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal92
进行中(未招募)
不适用
Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast CancerAnatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Lymph Node InvolvementPrognostic Stage II Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage IIB Breast Cancer AJCC v8Prognostic Stage III Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8Prognostic Stage IIIB Breast Cancer AJCC v8Prognostic Stage IIIC Breast Cancer AJCC v8
NCT03786354Ohio State University Comprehensive Cancer Center61
已完成
不适用
Lymphedema Severity on Shoulder Joint Function and Muscle Activation Patterns in Breast Cancer SurvivorsBreast Cancer FemaleBreast Cancer
NCT05934695Ahram Canadian University75
已完成
不适用
Body Awareness and Functionality in LymphedemaLymphedema of Upper Limb
NCT06036173Selcuk University102
已完成
不适用
Effect of Thera Band Exercises on Adhesive Capsulitis Post MastectomyAdhesive Capsulitis of Shoulder
NCT05311839Maged Basha70